[HTML][HTML] Soluble urokinase plasminogen activator receptor (suPAR) as a biomarker of systemic chronic inflammation

LJH Rasmussen, JEV Petersen… - Frontiers in …, 2021 - frontiersin.org
Systemic chronic inflammation (SCI) is persistent, health-damaging, low-grade inflammation
that plays a major role in immunosenescence and in development and progression of many …

Recent advancements of nanomodified electrodes–Towards point-of-care detection of cardiac biomarkers

AG Cardoso, SR Ahmed, Z Keshavarz-Motamed… - …, 2023 - Elsevier
The increasing number of deaths from cardiovascular diseases has become a substantial
concern in both developed and underdeveloped countries. Rapid and on-site monitoring of …

[HTML][HTML] Soluble urokinase receptor (SuPAR) in COVID-19–related AKI

TU Azam, HR Shadid, P Blakely… - Journal of the …, 2020 - journals.lww.com
Background AKI commonly occurs in patients with coronavirus disease 2019 (COVID-19). Its
pathogenesis is poorly understood. The urokinase receptor system is a key regulator of the …

[HTML][HTML] Increased soluble urokinase plasminogen activator levels modulate monocyte function to promote atherosclerosis

G Hindy, DJ Tyrrell, A Vasbinder, C Wei… - The Journal of …, 2022 - Am Soc Clin Investig
People with kidney disease are disproportionately affected by atherosclerosis for unclear
reasons. Soluble urokinase plasminogen activator receptor (suPAR) is an immune-derived …

Independent impact of periodontitis and cardiovascular disease on elevated soluble urokinase‐type plasminogen activator receptor (suPAR) levels

G Isola, A Polizzi, A Alibrandi… - Journal of …, 2021 - Wiley Online Library
Background Previous studies have demonstrated that a soluble urokinase‐type
plasminogen activator receptor (suPAR) plays an essential function in leukocytes and …

[PDF][PDF] Statins and C-reactive protein: in silico evidence on direct interaction

N Shakour, M Ruscica, F Hadizadeh, C Cirtori… - Archives of Medical …, 2020 - termedia.pl
Results Docking experiments showed that all statins could directly interact with CRP. Among
statins, rosuvastatin had the strongest interaction with CRP (pKi= 16.14), followed by …

[HTML][HTML] A systematic review and meta-analysis of advanced biomarkers for predicting incident cardiovascular disease among asymptomatic middle-aged adults

JL Romero-Cabrera, J Ankeny… - International Journal of …, 2022 - mdpi.com
Cardiovascular disease (CVD) continues as the most important cause of mortality. Better risk
screening and prediction are needed to reduce the cardiovascular disease burden. The aim …

[HTML][HTML] Effect of dietary inflammatory potential on the aging acceleration for cardiometabolic disease: A population-based study

Y Hu, X Wang, J Huan, L Zhang, L Lin, Y Li, Y Li - Frontiers in nutrition, 2022 - frontiersin.org
Background/Aim Optimized dietary patterns have been considered an important determinant
of delaying aging in cardiometabolic disease (CMD). Dietary pattern with high-level dietary …

[HTML][HTML] Subclinical doxorubicin-induced cardiotoxicity update: role of neutrophils and endothelium

VK Todorova, JY Wei, I Makhoul - American Journal of Cancer …, 2021 - ncbi.nlm.nih.gov
Doxorubicin (DOX) is a highly effective chemotherapy agent that often causes cardiotoxicity.
Despite a number of extensive studies, the risk for DOX cardiotoxicity remains unpredictable …

Involvement of circulating inflammatory factors in prognosis and risk of cardiovascular disease

H Haybar, M Shokuhian, M Bagheri, N Davari… - Journal of molecular and …, 2019 - Elsevier
Cardiovascular disease (CVD) is an inflammatory disease that different factors play a crucial
role in the development of clinical outcome of this disease. Inflammation could have effects …